Skip to main content
Premium Trial:

Request an Annual Quote

GenData and Amgen Sign Drug-, Diagnostic-Development Partnership

NEW YORK, Jan. 5 (GenomeWeb News) - GenData and Amgen will partner to develop drugs and diagnostics for an undisclosed disease, GenData said today.


Under the collaboration, Amgen will select genetic targets identified by GenData's population genetics discovery platform, based on the Utah Genetic Reference Product and the Utah Population Database. The drug maker will also pay GenData for "research activities, product-development milestones," and for products developed, according to GenData.


GenData, based in Salt Lake City, provides commercial access to the Utah Population Database, which contains more than seven million records, including genealogical records, population records, and vital statistics linked to medical information.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.